(1) Cai X, Shi S, Chen G, Zhong M, Yang Y, Mai Z, Tian Y, Tan J, He L, Cui C, Yu Z, Wang X*(通讯作者). Glutamine metabolism targeting liposomes for synergistic chemosensitization and starvation therapy in ovarian cancer. Acta Biomater. 2022 Dec 31:S1742-7061(22)00865-0. doi: 10.1016/j.actbio.2022.12.052. Epub ahead of print. PMID: 36596434.（IF=10.633）
(2) Li G, Ling M, Yu K, Yang W, Liu Q, He L, Cai X, Zhong M, Mai Z, Sun R, Xiao Y, Yu Z, Wang X*(通讯作者). Synergetic delivery of artesunate and isosorbide 5-mononitrate with reduction-sensitive polymer nanoparticles for ovarian cancer chemotherapy. J Nanobiotechnology. 2022 Nov 5;20(1):471. doi: 10.1186/s12951-022-01676-3. PMID: 36335352; PMCID: PMC9636721.（IF=9.429）
(3) Yang Z, Fu H, Su H, Cai X, Wang Y, Hong Y, Hu J, Xie Z, Wang X*(通讯作者). Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome. Front Microbiol. 2022;13:1017147.(IF: 6.064)
(4) Yang ZD#, Cai XZ#, Xu XX#, Xu ZM, Ye SM, Wang Y, Hong YJ, Shen BC, Liao QF, Xie ZY*, Wang XF*(通讯作者). Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome. Anal Biochem. 2022 23:114665. (IF: 3.365)
(5) Cai Xuzi., Wang Kang-Nan., Ma Wen., Yang Yuanyuan., Chen Gui., Fu Huijiao., Cui Chunhui., Yu Zhiqiang., Wang Xuefeng*(通讯作者). Multifunctional AIE iridium (III) photosensitizer nanoparticles for two-photon-activated imaging and mitochondria targeting photodynamic therapy. J Nanobiotechnology. 2021 Aug 23;19(1):254. (IF: 10.435)
(6) Li Guang, Liu Guobing, Wang Xuefeng*(通讯作者). PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.[J] .Biomed Res Int, 2021, 2021: 5512340. (IF: 3.411)
(7) Xie Ruirui., Yang Peipei., Liu Jiamin., Zou Xun., Tan Yilin., Wang Xuefeng*(共同通讯作者), Tao Jia., Zhao Peng. Lanthanide-functionalized metal-organic frameworks based ratiometric fluorescent sensor array for identification and determination of antibiotics. Talanta. 2021 Aug 15;231:122366.（SCI, IF 5.339)
(8) Li Yibing, Zhu Yilin, Cai Xuzi, Guo Jimin, Yao Cuiping, Pan Qiling, Wang Xuefeng*(共同通讯作者), Wang Kang-Nan. A benzothiazole-based near-infrared fluorescent probe for sensing SO derivatives and viscosity in HeLa cells.[J] .Spectrochim Acta A Mol Biomol Spectrosc, 2021, 251: 119457.（SCI, IF 3.232)
(9) Xuzi Cai,Huijiao Fu ,Yan Wang，Qiwen Liu, Xuefeng Wang *(通讯作者) . Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway in vitro.[J] .J Ovarian Res, 2020, 13: 136.（SCI, IF 2.989)
(10) Zhigang Chen, Xiaoxu Kang, Yixin Wu, Haihua Xiao, Xuzi cai, Shihou Sheng*, Xuefeng Wang *(共同通讯作者), Shiguo Chen*.A Mitochondria Targeting Artesunate Prodrug Loaded Nanoparticle Exerting Anticancer Acitivity via Iron-Mediated Generation of Reactive Oxygen Species. Chemical Communications.Pub Date:2019-03-20, DOI: 10.1039/C9CC00531E. （SCI, IF 6.29)
(11) Qiling Chen #,Yuanyuan Yang #, Xun Lin,Wen Ma,Gui Chen,Wenliang Li,Xuefeng Wang* (共同通讯作者) and Zhiqiang Yu *.Platinum( IV) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.Chem Commun (Camb).2018 May 22;54(42):5369-5372（SCI, IF 6.29)
(12) Zhou Chen, Cao Wu, Zhenfeng Zhang, Wangping Wu , Xuefeng Wang*(共同通讯作者), Zhiqiang Yu*. Synthesis, functionalization, and nanomedical applications of functional magnetic nanoparticles[J]. Chinese Chemical Letters, Available online August 18th, 2018.（SCI, IF 2.631)
(13) Xuefeng Wang（王雪峰）, Yuanli He, Mubiao Liu, Xiafei FU. Lentivirus-mediated bcl-2 gene therapy improves functions and structure of chemotherapy-damaged ovaries in rats . American Journal of Reproductive Immunology.2013，69（5）：427–528. (SCI，IF 3.05)
(14) Xuefeng Wang（王雪峰）,Yue Yang, Yanbing Huang, Qiongyao Wang. Association study of polymorphism of FXIIIVal34Leu gene and polycystic ovary syndrome.Int J Clin Exp Med 2014;7(11):4466-4470（SCI, IF 1.947)
(15) Peng Wu, Xuefeng Wang*(共同第一作者), Zigui Wang, Wen Ma, Jinshan Guo, Jianjun Chen, Zhiqiang Yu, Jizhen Li, and Dongfang Zhou.Light-Activatable Prodrug and AIEgen Copolymer Nanoparticle for Dual-Drug Monitoring and Combination Therapy[J].ACS Appl Mater Interfaces,,2019,11(20):18691-18700.(SCI, IF 8.097)
(16) Lu MZ#*, Li DY, Wang XF*(共同通讯作者). Effect of metformin use on the risk and prognosis of ovarian cancer: an updated systematic review and meta-analysis. Panminerva Med. 2019 Jul 8.(SCI, IF3.467)
(17) Yingmei Luo, Xuefeng Wang, Yi Cao. Transcriptomic-based toxicological investigations of graphene oxide with modest cytotoxicity to human umbilical vein endothelial cells: changes of Toll-like receptor signaling pathways. Toxicology Research. 2021 Oct 16;, tfab091, https://doi.org/10.1093/toxres/tfab091
(18) Lin Min., Weng Huinan., Wang Xuefeng., Zhou Bing., Yu Ping., Wang Yifeng. The role of tissue factor and protease-activated receptor 2 in endometriosis.[J] .Am J Reprod Immunol, 2012, 68: 251-7.(IF: 2.739)
(19) Fu Xiafei., He Yuanli., Wang Xuefeng., Peng Dongxian., Chen Xiaoying., Li Xinran., Wang Qing.(2017). Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis. Stem Cell Res Ther, 8(1), 187. (IF4.21)
(20) Yi X, Liu F, Gao K, Chen F, Wang Y, Li H, Wang X, Huang Y, Fu H, Zhou W, Fan JB, Wang S, Gao Y. Reconstructable Uterus-Derived Materials for Uterus Recovery towards Efficient Live Births. Adv Mater. 2021 Dec 1:e2106510. (IF: 30.849).
(21) 何丽清#,蔡序子,王艳,王雪峰*(通讯作者).生育指数预测EAI术后妊娠率及指导治疗的临床价值.解放军医学杂志.2018,43(08):668-673.
(22) 何丽清#,蔡序子,王艳,王雪峰*(通讯作者).子宫内膜异位症腹腔镜保守治疗术后联用GnRHa对临床妊娠率的影响[J].南方医科大学学报,2018,38(05):596-600.
(23) 王艳,何丽清,蔡序子,王雪峰*(通讯作者).派特灵治疗高危人乳头瘤病毒持续感染患者的疗效及安全性研究[J].中国全科医学,2019,22(11):1323-1327.
(24) 池佼妮#,庞永辉,刘娜,方俊杰,李焕强,王雪峰*(通讯作者).遗传学因素与早发性卵巢功能不全的研究进展[J].实用妇产科杂志,2018,34(01):26-29.